Olink Explore HT
Talk to a Specialist
Capture true biological insights with proven specificity. At any scale.
Olink® Explore HT
Perform high-throughput biomarker discovery with ease to understand disease at the protein level.
Unprecedented power
Olink Explore HT is the next-generation solution for high-throughput proteomics. Run in your own lab, access via our worldwide network of service providers, or at Olink Analysis Services.
Overview
Proteins
5,400+With proven specificity
Sample
2 µLPlasma, serum & more
Specificity
99.5%Negligible cross-reactivity
Throughput
4xIncrease over previous generation
Dynamic range
fg-mg/mL10 logs
Readout
NGSAutomated workflow
Developed for specificity, validated for quality
Our dual-recognition, DNA-coupled technology delivers industry-leading specificity, eliminating wrong targets, misinterpretation and wasted resources. Every assay undergoes a rigorous validation process, ensuring quality data you can trust.
Carefully curated to provide deeper biological insights
Our protein selection strategy focuses on functional, actionable, druggable, and circulating proteins. Drawn from protein annotations, publications, clinical trials, approved therapies, and researcher requests.
Biomarker coverage
Intelligently selected
5,400+Validated protein assays
High coverage
+85%More than previous generation
Full top-level coverage
100%Of top-level pathways
Realize any project you can imagine
Olink Explore HT is designed for outstanding performance at any scale of protein biomarker discovery, from tens to millions of samples. This scalability is enabled by a streamlined, automated workflow and a comprehensive software suite, all optimized for high-throughput data acquisition.
Workflow
4x faster
Compared to previous generation
Project completion
Analyze 50,000 samples in 12 weeks
With two instrumentation lines
Throughput
11 million
datapoints per week with a single instrumentation line
Revealing the truth of human disease. Protein by protein.
Olink’s trusted proteomics solutions are helping to bridge the gap between genomics and human diseases. Population-scale studies are increasingly being used to provide comprehensive views of protein expression patterns across the diversity of human biology. Olink technology has been applied to one of the world’s largest proteomic health studies, revealing biomarkers that can predict cancer more than a decade before diagnosis.
Olink Explore enabled the pioneering UK Biobank Pharma Proteomics Project. This ongoing population-scale project, backed by a pharma consortium, applied the Olink Explore platform for proteomic analysis of over 54,000 participants. To date, over 20,000 genetic associations for ~3,000 proteins have been identified, with much more to come. The protein data is freely available in Olink Insight.
More data. Less effort.
Accelerate your biomarker discovery with a faster workflow and significant reagent reduction. With Olink Explore HT, we’ve reimagined our packaging, resulting in a 10-fold reduction in boxes and a 6-fold decrease in components. The new NPX Explore HT software suite simplifies data analysis, allowing you to derive actionable biological findings faster.
Efficiency
Data points
7x moreto reveal additional biological insights
Components
6x fewerto save time and resources
Scalability and flexibility in data processing
Experience unmatched scalability and flexibility in data processing. Our custom software ensures consistent data across platforms, allowing you to operate and access your data anytime, anywhere –be it desktop, CLI, office, or lab. We provide advanced tools and features that simplify data understanding and empower you to make informed decisions about data re-runs.
NPX Explore 3072 & HT
Desktop analysis software
NPX Explore 3072 & HT is equipped with product-specific views and allows you to easily visualize data, detect potential errors in lab workflows – ensuring data you can trust.
NPX Explore 3072 & HT CLI
Command-line interface
We offer a powerful CLI to complement our desktop software, enabling efficient large-scale data set analysis. It integrates seamlessly with laboratory LIMS and extends to the downstream data analysis pipeline.
Quality control
Built-in QC
A new integrated software concept for better, faster quality control, minimizing manual steps, and optimizing your data pipeline.
Amplify discovery.
Advance genomics.
When you combine proteomic data with genomic datasets, your statistical significance skyrockets. Olink data is designed for maximum transparency and comparability – whether you’re investigating novel drug targets or digging deeper into existing sample collections to repurpose on-market therapies.
Documents
Below you will find a few documents related to this product. For the complete documentation including SDS, user manuals, technical notes and more, visit the documents section.
| Documents | Type | File |
|---|---|---|
| Advancing biomarker discovery in ovarian cancer with Olink® Explore HT | Case studies | Download PDF |
| PEA: Exceptional specificity in a high multiplex format | White paper |
A flexible platform that accelerates your research
Olink’s scalable technology provides optimized solutions for every stage of the biomarker workflow, from high-throughput discovery through validation and clinical utility.
Get help choosing.Talk to a Specialist
Olink Target 96
Target specific disease areas or key biological processes with multiplex immunoassay panels.
Proteins
1,100+On 15 targeted panels
Sample
1 µLPlasma, serum & more
Learn more
Olink Target 48
Extensively validated and carefully selected biomarkers for a comprehensive view of cytokine signaling and inflammatory processes.
Proteins
89On 2 panels
Sample
1 µLPlasma, serum & more
Learn more
Olink Flex
Run individually tailored studies by combining up to 21 biomarkers from our extensive library with minimal sample volume.
Proteins
~200Pre-validated assays
Sample
1 µLPlasma, serum & more
Learn more
Olink Focus
Custom designed panels that transition you from biomarker discovery to clinical utility of protein signatures.
Proteins
Up to 21Pre-validated assays
Sample
1 µLPlasma, serum & more
Learn more
